É. Tremblay

Sodium glucose cotransporter 2 inhibitors and risk of major adverse cardiovascular events: multi-database retrospective cohort study

L. Lix, S. Suissa, C. Dormuth, 2020, BMJ.

Doctor shopping among chronic noncancer pain patients treated with opioids in the province of Quebec (Canada): incidence, risk factors, and association with the occurrence of opioid overdoses

M. Choinière, M. Pagé, A. Lacasse, 2021, Pain reports.

[Development of quality of care indicators to support chronic disease management].

M. Beaulieu, M. Pomey, Claudio Del Grande, 2015, Sante publique.

Quality of hypertension pharmacotherapy in Quebec: a population-based study.

L. Guénette, M. Gaudet, É. Tremblay, 2014, Journal of population therapeutics and clinical pharmacology = Journal de la therapeutique des populations et de la pharamcologie clinique.

Sodium–Glucose Cotransporter-2 Inhibitors and the Risk for Diabetic Ketoacidosis

L. Lix, K. Filion, B. Shah, 2020, Annals of Internal Medicine.

Sodium-glucose Cotransporter 2 Inhibitors and the Risk for Urosepsis - A Multi-site Prevalent New-user Cohort Study.

L. Lix, K. Filion, B. Shah, 2020, Diabetes, obesity & metabolism.

Persistence with denosumab and zoledronic acid among older women: a population-based cohort study

M. Dorais, S. Perreault, É. Tremblay, 2016, Archives of Osteoporosis.